Rocky Mountain spotted fever vaccine in an animal model

J. D. Folds, David Walker, B. C. Hegarty, D. Banasiak, J. V. Lange

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Formalin-killed, purified Rickettsia rickettsii vaccine was evaluated in a guinea pig model of R. rickettsii infection. Vaccinated guinea pigs were partially protected by the vaccine when challenged with virulent, viable rickettsiae. Greater protection was observed when higher doses of vaccine were given and when frequent booster injections were administered. Stimulation of cell-mediated immunity to the vaccine antigens was variable and also appeared to be achieved more reproducibly with booster vaccinations. Serum antibody was elicited by high doses of vaccine and by booster vaccinations. The presence of serum antibody was useful in predicting immunity to challenge with R. rickettsii.

Original languageEnglish (US)
Pages (from-to)321-326
Number of pages6
JournalJournal of Clinical Microbiology
Volume18
Issue number2
StatePublished - 1983
Externally publishedYes

Fingerprint

Rocky Mountain Spotted Fever
Rickettsia rickettsii
Vaccines
Animal Models
Guinea Pigs
Vaccination
Rickettsia Infections
Rickettsia
Antibodies
Serum
Cellular Immunity
Formaldehyde
Immunity
Antigens
Injections

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Folds, J. D., Walker, D., Hegarty, B. C., Banasiak, D., & Lange, J. V. (1983). Rocky Mountain spotted fever vaccine in an animal model. Journal of Clinical Microbiology, 18(2), 321-326.

Rocky Mountain spotted fever vaccine in an animal model. / Folds, J. D.; Walker, David; Hegarty, B. C.; Banasiak, D.; Lange, J. V.

In: Journal of Clinical Microbiology, Vol. 18, No. 2, 1983, p. 321-326.

Research output: Contribution to journalArticle

Folds, JD, Walker, D, Hegarty, BC, Banasiak, D & Lange, JV 1983, 'Rocky Mountain spotted fever vaccine in an animal model', Journal of Clinical Microbiology, vol. 18, no. 2, pp. 321-326.
Folds JD, Walker D, Hegarty BC, Banasiak D, Lange JV. Rocky Mountain spotted fever vaccine in an animal model. Journal of Clinical Microbiology. 1983;18(2):321-326.
Folds, J. D. ; Walker, David ; Hegarty, B. C. ; Banasiak, D. ; Lange, J. V. / Rocky Mountain spotted fever vaccine in an animal model. In: Journal of Clinical Microbiology. 1983 ; Vol. 18, No. 2. pp. 321-326.
@article{8077063de2134dc9a987f920eda7b914,
title = "Rocky Mountain spotted fever vaccine in an animal model",
abstract = "Formalin-killed, purified Rickettsia rickettsii vaccine was evaluated in a guinea pig model of R. rickettsii infection. Vaccinated guinea pigs were partially protected by the vaccine when challenged with virulent, viable rickettsiae. Greater protection was observed when higher doses of vaccine were given and when frequent booster injections were administered. Stimulation of cell-mediated immunity to the vaccine antigens was variable and also appeared to be achieved more reproducibly with booster vaccinations. Serum antibody was elicited by high doses of vaccine and by booster vaccinations. The presence of serum antibody was useful in predicting immunity to challenge with R. rickettsii.",
author = "Folds, {J. D.} and David Walker and Hegarty, {B. C.} and D. Banasiak and Lange, {J. V.}",
year = "1983",
language = "English (US)",
volume = "18",
pages = "321--326",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Rocky Mountain spotted fever vaccine in an animal model

AU - Folds, J. D.

AU - Walker, David

AU - Hegarty, B. C.

AU - Banasiak, D.

AU - Lange, J. V.

PY - 1983

Y1 - 1983

N2 - Formalin-killed, purified Rickettsia rickettsii vaccine was evaluated in a guinea pig model of R. rickettsii infection. Vaccinated guinea pigs were partially protected by the vaccine when challenged with virulent, viable rickettsiae. Greater protection was observed when higher doses of vaccine were given and when frequent booster injections were administered. Stimulation of cell-mediated immunity to the vaccine antigens was variable and also appeared to be achieved more reproducibly with booster vaccinations. Serum antibody was elicited by high doses of vaccine and by booster vaccinations. The presence of serum antibody was useful in predicting immunity to challenge with R. rickettsii.

AB - Formalin-killed, purified Rickettsia rickettsii vaccine was evaluated in a guinea pig model of R. rickettsii infection. Vaccinated guinea pigs were partially protected by the vaccine when challenged with virulent, viable rickettsiae. Greater protection was observed when higher doses of vaccine were given and when frequent booster injections were administered. Stimulation of cell-mediated immunity to the vaccine antigens was variable and also appeared to be achieved more reproducibly with booster vaccinations. Serum antibody was elicited by high doses of vaccine and by booster vaccinations. The presence of serum antibody was useful in predicting immunity to challenge with R. rickettsii.

UR - http://www.scopus.com/inward/record.url?scp=0020632224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020632224&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 321

EP - 326

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 2

ER -